Template:Bleeding: Difference between revisions

	Bleeding Microchapters
Home
Patient Information
Overview
Classification
Bleeding Academic Research Consortium
TIMI bleeding criteria
GUSTO bleeding criteria
CURE bleeding criteria
ACUITY HORIZONS bleeding criteria
STEEPLE bleeding criteria
PLATO bleeding criteria
GRACE bleeding criteria
Causes
Treatment
Emergency Bleeding Control
Reversal of Anticoagulation and Antiplatelet in Active Bleed
Perioperative Bleeding
Anemia Management
Coagulation Monitoring
Coagulation Management
Discontinuation, Bridging, and Reversal of Anticoagulation and Antiplatelet Therapy Antiplatelet Agents Heparin Fondaparinux Vitamin K Antagonists New Oral Anticoagulants Comorbidities Involving Hemostatic Derangement
Specific Surgeries Cardiovascular Surgery Gynecological Bleeding Obstetric Bleeding Orthopedic/Neurosurgery Visceral/Transplant Surgery Pediatric Surgery
Congenital Bleeding Disorders von Willebrand Disease Platelet Defects Hemophilia A and B Factor VII Deficiency Rare Bleeding Disorders
Bleeding On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Bleeding All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Bleeding
CDC on Bleeding
Bleeding in the news
Blogs on Bleeding
Directions to Hospitals Treating Bleeding
Risk calculators and risk factors for Bleeding

VisualWikitext

@@ Line 1: / Line 1: @@
-{| class="infobox bordered" style="width: 15%; text-align: left; font-size: 85%; background:AliceBlue"
+{| class="infobox bordered" style="width: 18%; text-align: left; font-size: 85%; background:AliceBlue"
 |-
 | colspan="1" style="text-align:center; background:DarkGray" |
 '''Bleeding Microchapters'''
 |- bgcolor="LightGrey"
 !
@@ Line 28: / Line 29: @@
 |- bgcolor="Pink"
 !
-:[[Bleeding Academic Research Consortium]]
+: [[Bleeding Academic Research Consortium]]
 |-
 !
 |- bgcolor="Pink"
 !
-:[[TIMI bleeding criteria]]
+: [[TIMI bleeding criteria]]
 |-
 !
 |- bgcolor="Pink"
 !
-:[[GUSTO bleeding criteria]]
+: [[GUSTO bleeding criteria]]
 |-
 !
 |- bgcolor="Pink"
 !
-:[[CURE bleeding criteria]]
+: [[CURE bleeding criteria]]
 |-
 !
 |- bgcolor="Pink"
 !
-:[[ACUITY HORIZONS bleeding criteria]]
+: [[ACUITY HORIZONS bleeding criteria]]
 |-
 !
 |- bgcolor="Pink"
 !
-:[[STEEPLE bleeding criteria]]
+: [[STEEPLE bleeding criteria]]
 |-
 !
 |- bgcolor="Pink"
 !
-:[[PLATO bleeding criteria]]
+: [[PLATO bleeding criteria]]
 |-
 !
 |- bgcolor="Pink"
 !
-:[[GRACE bleeding criteria]]
+: [[GRACE bleeding criteria]]
 |-
 !
@@ Line 81: / Line 82: @@
 |-
 !
 |- bgcolor="PaleTurquoise"
 !
@@ Line 94: / Line 94: @@
 |- bgcolor="PaleTurquoise"
 !
-: [[Perioperative bleeding coagulation monitoring|Coagulation Monitoring]]
+: [[Bleeding perioperative bleeding anemia management|Anemia Management]]
 |-
 !
 |- bgcolor="PaleTurquoise"
 !
-: [[Perioperative bleeding anemia management|Anemia Management]]
+: [[Bleeding perioperative bleeding monitoring of coagulation status and platelet function|Coagulation Monitoring]]
 |-
 !
 |- bgcolor="PaleTurquoise"
 !
-: [[Perioperative bleeding coagulation management|Coagulation Management]]
+: [[Bleeding perioperative bleeding coagulation management|Coagulation Management]]
 |-
 !
 |- bgcolor="PaleTurquoise"
 !
-:[[Perioperative bleeding discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy|Discontinuation, Bridging, and Reversal of Anticoagulation and Antiplatelet Therapy]]
+: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy|Discontinuation, Bridging, and Reversal of Anticoagulation and Antiplatelet Therapy]]
+:: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy#Antiplatelet Agents|Antiplatelet Agents]]
+:: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy#Heparin|Heparin]]
+:: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy#Fondaparinux|Fondaparinux]]
+:: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy#Vitamin K Antagonists|Vitamin K Antagonists]]
+:: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy#New Oral Anticoagulants|New Oral Anticoagulants]]
+:: [[Bleeding perioperative discontinuation, bridging, and reversal of anticoagulation and antiplatelet therapy#Comorbidities Involving Hemostatic Derangement|Comorbidities Involving Hemostatic Derangement]]
 |-
 !
 |- bgcolor="PaleTurquoise"
 !
-: [[Perioperative bleeding management in specific surgeries|Specific Surgeries]]
+: [[Bleeding perioperative bleeding management in specific surgeries|Specific Surgeries]]
+:: [[Bleeding perioperative bleeding management in specific surgeries#Cardiovascular Surgery|Cardiovascular Surgery]]
+:: [[Bleeding perioperative bleeding management in specific surgeries#Gynecological (Non-Pregnant) Bleeding|Gynecological Bleeding]]
+:: [[Bleeding perioperative bleeding management in specific surgeries#Obstetric Bleeding|Obstetric Bleeding]]
+:: [[Bleeding perioperative bleeding management in specific surgeries#Orthopedic Surgery and Neurosurgery|Orthopedic/Neurosurgery]]
+:: [[Bleeding perioperative bleeding management in specific surgeries#Visceral and Transplant Surgery|Visceral/Transplant Surgery]]
+:: [[Bleeding perioperative bleeding management in specific surgeries#Pediatric Surgery|Pediatric Surgery]]
 |-
 !

Template:Bleeding: Difference between revisions

Latest revision as of 13:10, 25 April 2014

Navigation menu